Image source: Getty Images
According to a survey by Greenwald Research, 52% of workers have calcu...
It would probably be a mistake to simply forget about net-lease giant Realty Income (NYSE: O). It is...
Fool.com contributor Parkev Tatevosian reviews why everyone is discussing Nvidia (NASDAQ: NVDA) stoc...
Dividend-paying tech stocks were once a rare breed. But this year big names in tech have suddenly st...
Natural gas storage plays a vital role in the energy sector. Gas storage facilities help balance nat...
Shares of Bank of America (NYSE: BAC) have done quite well recently. As of this writing, they have s...
Jamie Dimon, the CEO of JPMorgan Chase (NYSE: JPM), is one of the most listened-to voices in finance...
Shares of cybersecurity powerhouse Palo Alto Networks (NASDAQ: PANW) experienced a resurgence in rec...
Image source: Getty Images
When my husband and I took a trip to Hawaii years back, we were initia...
The stock market has gotten off to a sizzling start in 2024. Both the S&P 500 and Nasdaq Composi...
Most investors who buy tech stocks do so for the potential for high growth and share price appreciat...
Image source: Upsplash/The Motley Fool
I once bought a used Nissan Altima for $4,000 and drove it...
Nvidia (NASDAQ: NVDA) has been a great stock to own, and it could remain that way for long-term inve...
Raging hot inflation has made it harder to find value in anything these days. A $20 bill doesn't go ...
Dividend stocks can be boring, especially when AI-fueled stock gains are proliferating. Still, for l...
Image source: Getty Images
In a few weeks, I'll be setting sail with my wife, kids, and several f...
Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just abo...
There are still some businesses reporting their most recent quarterly results. AutoZone (NYSE: AZO) ...
Image source: Getty Images
I've got to be honest with you. When I first saw that CDs were paying ...
The artificial intelligence (AI) revolution is well underway. Kickstarted by OpenAI's ChatGPT introd...
As its shareholders already know, CRISPR Therapeutics (NASDAQ: CRSP) has quite a few opportunities o...